Anti-ROR1 antibodies and methods of making and using thereof
Abstract:
The application provides anti-ROR1 monoclonal antibodies, antigen binding portions thereof, therapeutic compositions thereof and/or nucleic acid encoding the same, and their use to upregulate the function of T-cells to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders.
Public/Granted literature
Information query
Patent Agency Ranking
0/0